Submitted by Anonymous (not verified) on Tue, 08/15/2017 - 22:18
Forest Labs beats class certification bid in antidepressant marketing caseReutersA federal judge on Tuesday denied class certification in a lawsuit claiming Allergan PLC's Forest Laboratories unit misled the public about the efficacy of its antidepressants Celexa and Lexapro in treating major depressive disorder in children.
